{"pmid":32322034,"title":"Hundreds of people volunteer to be infected with coronavirus.","text":["Hundreds of people volunteer to be infected with coronavirus.","Nature","Callaway, Ewen","32322034"],"journal":"Nature","authors":["Callaway, Ewen"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32322034","week":"202017|Apr 20 - Apr 26","doi":"10.1038/d41586-020-01179-x","keywords":["diseases","ethics","vaccines"],"source":"PubMed","topics":["General Info"],"weight":1,"_version_":1664895932780511233,"score":8.518259,"similar":[{"pmid":32218549,"title":"Should scientists infect healthy people with the coronavirus to test vaccines?","text":["Should scientists infect healthy people with the coronavirus to test vaccines?","Nature","Callaway, Ewen","32218549"],"journal":"Nature","authors":["Callaway, Ewen"],"date":"2020-03-29T11:00:00Z","year":2020,"_id":"32218549","week":"202013|Mar 23 - Mar 29","doi":"10.1038/d41586-020-00927-3","keywords":["diseases","ethics","infection"],"source":"PubMed","topics":["General Info"],"weight":1,"_version_":1664638743026335745,"score":73.67238},{"pmid":32157230,"title":"Why does the coronavirus spread so easily between people?","text":["Why does the coronavirus spread so easily between people?","Nature","Mallapaty, Smriti","32157230"],"journal":"Nature","authors":["Mallapaty, Smriti"],"date":"2020-03-12T11:00:00Z","year":2020,"_id":"32157230","week":"202011|Mar 09 - Mar 15","doi":"10.1038/d41586-020-00660-x","keywords":["infection","vaccines"],"source":"PubMed","topics":["General Info"],"weight":1,"_version_":1664640874816995330,"score":53.48921},{"pmid":32232474,"title":"Human challenge studies to accelerate coronavirus vaccine licensure.","text":["Human challenge studies to accelerate coronavirus vaccine licensure.","Controlled human challenge trials of SARS-CoV-2 vaccine candidates could accelerate the testing and potential rollout of efficacious vaccines. By replacing conventional Phase 3 testing of vaccine candidates, such trials may subtract many months from the licensure process, making efficacious vaccines available more quickly. Obviously, challenging volunteers with this live virus risks inducing severe disease and possibly even death. However, we argue that such studies, by accelerating vaccine evaluation, could reduce the global burden of coronavirus-related mortality and morbidity. Volunteers in such studies could autonomously authorize the risks to themselves, and their net risk could be acceptable if participants comprise healthy young adults, who are at relatively low risk of serious disease following natural infection, they have a high baseline risk of natural infection, and during the trial they receive frequent monitoring and, following any infection, the best available care.","J Infect Dis","Eyal, Nir","Lipsitch, Marc","Smith, Peter G","32232474"],"abstract":["Controlled human challenge trials of SARS-CoV-2 vaccine candidates could accelerate the testing and potential rollout of efficacious vaccines. By replacing conventional Phase 3 testing of vaccine candidates, such trials may subtract many months from the licensure process, making efficacious vaccines available more quickly. Obviously, challenging volunteers with this live virus risks inducing severe disease and possibly even death. However, we argue that such studies, by accelerating vaccine evaluation, could reduce the global burden of coronavirus-related mortality and morbidity. Volunteers in such studies could autonomously authorize the risks to themselves, and their net risk could be acceptable if participants comprise healthy young adults, who are at relatively low risk of serious disease following natural infection, they have a high baseline risk of natural infection, and during the trial they receive frequent monitoring and, following any infection, the best available care."],"journal":"J Infect Dis","authors":["Eyal, Nir","Lipsitch, Marc","Smith, Peter G"],"date":"2020-04-02T11:00:00Z","year":2020,"_id":"32232474","week":"202014|Mar 30 - Apr 05","doi":"10.1093/infdis/jiaa152","keywords":["coronavirus","ethics","human challenge studies","randomized controlled trials","risk-taking","vaccines"],"source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1664638455334830080,"score":50.750553},{"pmid":32241929,"title":"Infect volunteers to speed a coronavirus vaccine?","text":["Infect volunteers to speed a coronavirus vaccine?","Science","Cohen, Jon","32241929"],"journal":"Science","authors":["Cohen, Jon"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32241929","week":"202014|Mar 30 - Apr 05","doi":"10.1126/science.368.6486.16","source":"PubMed","topics":["General Info"],"weight":1,"_version_":1664638249419669504,"score":49.75868},{"pmid":32286539,"title":"People power: How India is attempting to slow the coronavirus.","text":["People power: How India is attempting to slow the coronavirus.","Nature","Vaidyanathan, Gayathri","32286539"],"journal":"Nature","authors":["Vaidyanathan, Gayathri"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32286539","week":"202016|Apr 13 - Apr 19","doi":"10.1038/d41586-020-01058-5","keywords":["diseases","government","health care","infection","public health"],"source":"PubMed","topics":["General Info"],"weight":1,"locations":["India"],"countries":["India"],"countries_codes":["IND|India"],"_version_":1664636391711047681,"score":45.372204}]}